1,796 material Form 8-K filings that 1,448 companies we cover made with the SEC in May 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gap Inc. reported first quarter fiscal 2026 net sales of $3.5 billion, up 1%, and GAAP diluted EPS of $0.90 versus $0.51 a year earlier. Results include a $313 million net gain from a credit card interchange fee litigation settlement and a $50 million charitable contribution; excluding these items, adjusted diluted EPS was $0.38. The company raised its adjusted fiscal 2026 EPS outlook to $2.30 to $2.40 from $2.20 to $2.35, but lowered its net sales growth outlook to 1% to 2% from 2% to 3%.
Net sales of $3.5 billion were up 1%; comparable sales were up 2%, the ninth consecutive quarter of positive comparable sales.
Gross margin was 40.5%, down 130 basis points; merchandise margin was down 100 basis points, including an estimated net tariff impact of about 200 basis points.
Returned $464 million to shareholders in the quarter, including a $200 million accelerated share repurchase and $201 million of open-market repurchases.
Adjusted FY2026 diluted EPS outlook is $2.30 to $2.40, up from $2.20 to $2.35; net sales outlook is 1% to 2%, down from 2% to 3%.
Photronics reported second quarter fiscal 2026 revenue of $209.9 million, down 0.5% from a year earlier and 6.7% from the prior quarter. GAAP net income attributable to shareholders was $31.4 million, or $0.54 per diluted share, up from $0.15 a year earlier but down from $0.74 in the first quarter. The company expects third quarter revenue of $207 million to $215 million and non-GAAP diluted EPS of $0.39 to $0.45.
Revenue of $209.9 million was down 0.5% year-over-year and 6.7% sequentially
GAAP diluted EPS was $0.54, versus $0.15 a year earlier and $0.74 in the first quarter; non-GAAP diluted EPS was $0.42, versus $0.40 a year earlier
Operating margin was 20.1%, versus 24.4% in the first quarter and 26.4% a year earlier
Third quarter fiscal 2026 guidance: revenue of $207 million to $215 million, operating margin of 18% to 20%, and non-GAAP diluted EPS of $0.39 to $0.45
Hormel reported fiscal second-quarter 2026 net sales of $2.97 billion, up 2.5% from a year earlier, but GAAP operating income fell to $217 million from $248 million and GAAP diluted EPS was $0.29 versus $0.33. The company lowered its fiscal 2026 GAAP diluted EPS guidance to $1.28 to $1.37 from $1.37 to $1.46, reflecting the $61 million loss on the whole-bird turkey sale, while reaffirming adjusted diluted EPS guidance of $1.43 to $1.51.
Q2 net sales $2.97 billion, up 2.5%; organic net sales up 3%
Q2 GAAP diluted EPS $0.29 vs $0.33 a year earlier; adjusted diluted EPS $0.40 vs $0.35
Fiscal 2026 GAAP diluted EPS guidance cut to $1.28 to $1.37 from $1.37 to $1.46; adjusted EPS guidance reaffirmed at $1.43 to $1.51
Loss on the whole-bird turkey business sale, including transaction costs, was $61 million in the quarter
HP reported fiscal 2026 second-quarter results on May 27, 2026, with net revenue of $14.4 billion, up 9.0%, and non-GAAP diluted EPS of $0.86, up 21.1%. GAAP diluted EPS of $0.49 was below the company's prior outlook of $0.52 to $0.58, and restructuring and other charges reached $365 million, and HP updated its fiscal 2026 EPS and free cash flow estimates.
Net revenue of $14.4 billion, up 9.0% year over year; GAAP diluted EPS of $0.49, up from $0.42 but below the prior outlook of $0.52 to $0.58
Non-GAAP diluted EPS of $0.86, up from $0.71 and above the prior outlook of $0.70 to $0.76
Restructuring and other charges of $365 million in the quarter, compared with $122 million a year earlier
Fiscal 2026 estimates: GAAP diluted EPS $2.15 to $2.45, non-GAAP diluted EPS $2.90 to $3.10, free cash flow $2.8 to $3.0 billion
Synopsys reported second-quarter fiscal 2026 revenue of $2.276 billion, up from $1.604 billion a year earlier, and raised its full-year revenue and non-GAAP EPS targets. GAAP net income fell to $17.1 million, or $0.09 per diluted share, from $349.2 million a year earlier, and included $115.9 million in restructuring charges.
Q2 revenue $2.276 billion vs $1.604 billion a year earlier; non-GAAP EPS $3.35 vs $3.67.
GAAP net income $17.1 million ($0.09 per diluted share) vs $349.2 million ($2.24) a year earlier.
Full-year fiscal 2026 revenue midpoint raised to $9.665 billion from $9.610 billion; non-GAAP EPS midpoint raised to $14.76.
Marvell reported first-quarter fiscal 2027 revenue of $2.418 billion, a record and up 28% from a year earlier, and guided second-quarter revenue to $2.7 billion at the mid-point. GAAP net income fell to $34.5 million, or $0.04 per diluted share, from $177.9 million a year earlier, mainly because of a $250.7 million special item, while non-GAAP diluted EPS rose to $0.80 from $0.62. The company said it is raising its revenue outlook for both fiscal 2027 and fiscal 2028.
Q1 fiscal 2027 net revenue was $2.418 billion, up 28% year over year and $18.0 million above the mid-point of guidance given March 5, 2026
GAAP diluted EPS was $0.04 versus $0.20 a year earlier; non-GAAP diluted EPS was $0.80 versus $0.62
Q2 fiscal 2027 revenue guidance is $2.700 billion, plus or minus 5%, with non-GAAP diluted EPS guided to $0.93, plus or minus $0.05
Abercrombie & Fitch reported first-quarter fiscal 2026 net sales of $1.1 billion, up 2% from last year, with comparable sales down 1%. Diluted earnings per share fell to $1.47 from $1.59, and operating margin fell to 8.0% from 9.3%, though the company said EPS exceeded its outlook range. The company kept its full-year outlook unchanged, which matters to shareholders because it signals no change to its earnings or sales targets despite weaker EMEA demand.
Net sales of $1.1 billion, up 2%; comparable sales down 1%; EMEA sales down 10%, APAC up 24%
Diluted EPS of $1.47 vs. $1.59 a year earlier; operating margin of 8.0% vs. 9.3%
Full-year outlook maintained: net sales growth of 3% to 5%, diluted EPS of $10.20 to $11.00, share repurchases of around $450 million
Repurchased $105 million of shares in the quarter, with $745 million remaining on the March 2025 authorization
Bath & Body Works reported first quarter 2026 net sales of $1,378 million, down 3% from a year earlier, and reaffirmed its full-year 2026 guidance. Reported earnings per diluted share rose to $0.90 from $0.49, but that figure includes an $88 million pre-tax litigation settlement gain and a $62 million tax benefit, while adjusted EPS was $0.32 versus $0.49 last year. Chief Financial Officer Eva Boratto will step down June 12, and Tom Javitch will serve as interim CFO while the company searches for a successor.
Q1 2026 net sales were $1,378 million, down 3% from $1,424 million in Q1 2025.
Reported diluted EPS was $0.90 versus $0.49; adjusted diluted EPS was $0.32 versus $0.49.
Full-year 2026 guidance reaffirmed: net sales down 4.5% to 2.5%, adjusted diluted EPS $2.40 to $2.65.
Second-quarter 2026 diluted EPS is expected at $0.20 to $0.25; CFO Eva Boratto steps down June 12 and Tom Javitch becomes interim CFO.
DICK'S reported first-quarter net sales of $5.16 billion, up 62.7% from a year earlier, with the Foot Locker acquisition included for the full quarter. GAAP diluted earnings per share rose to $3.54 from $3.24, but non-GAAP earnings per share fell to $2.90 from $3.37, and the company lowered its full-year GAAP earnings per share guidance while keeping its non-GAAP range unchanged.
First-quarter net sales $5.16 billion vs. $3.18 billion a year earlier; Foot Locker acquisition closed September 8, 2025
Diluted EPS $3.54 GAAP vs. $3.24 prior year; non-GAAP $2.90 vs. $3.37
Full-year 2026 GAAP diluted EPS guidance cut to $13.27 to $14.27 from $13.70 to $14.70; non-GAAP range of $13.50 to $14.50 unchanged
DICK'S Business comparable sales outlook low end raised to 2.5% from 2.0%; quarterly dividend of $1.25 per share payable June 26, 2026
Transcat reported fiscal fourth quarter 2026 results for the period ended March 28, 2026, with revenue up 15.8% to $89.3 million while net income fell 56.4% to $1.9 million and diluted EPS fell to $0.21 from $0.48. For the full fiscal year, revenue rose 19.2% to $331.9 million, but net income fell 63.0% to $5.4 million, and the company expects high single-digit service organic revenue growth in fiscal 2027.
Q4 fiscal 2026 revenue was $89.3 million, up 15.8%, with service revenue up 18.4% to $61.6 million and distribution revenue up 10.5% to $27.8 million.
Q4 operating income fell 37.6% to $4.3 million, and net income fell to $1.9 million from $4.5 million a year earlier.
Adjusted EBITDA rose 16.0% to $14.8 million in Q4, while total debt was $99.9 million as of March 28, 2026, up from $32.7 million a year earlier.
Management guided to high single-digit service organic revenue growth for fiscal 2027, assuming a stable economic environment.
The Cato Corporation reported first-quarter net income of $9.3 million, or $0.47 per diluted share, versus $3.3 million, or $0.17, a year earlier, with sales of $169.5 million, up 0.7%. Management said the results were significantly helped by an IEEPA tariff refund claim and expects sales to be negatively affected by rising inflation, especially fuel and food prices.
Net income was $9.3 million, or $0.47 per diluted share, for the quarter ended May 2, 2026, compared with $3.3 million, or $0.17, a year earlier.
Sales were $169.5 million, up 0.7%, and same-store sales increased 3%.
A pre-tax $5.7 million tariff refund claim helped lift gross margin to 37.2% of sales from 35.1%.
Management expects sales to be negatively affected by inflation, especially fuel and food prices, and the company operated 1,065 stores as of May 2, 2026.
CSW Industrials reported fiscal fourth-quarter 2026 results for the period ended March 31, 2026, with revenue up 34.0% to a record $309.0 million, driven mainly by acquisitions. Diluted EPS fell 41.1% to $1.22, mainly because of a $15.6 million non-cash impairment and higher interest expense, while adjusted EPS rose 21.1% to $3.14.
Q4 revenue of $309.0 million, up 34.0% from the prior-year quarter; organic growth was $6.4 million, or 2.8%
Q4 diluted EPS of $1.22, down 41.1% from $2.08; adjusted EPS of $3.14, up 21.1% from $2.59
Fiscal 2026 revenue of $1.1 billion, up 23.3%; diluted EPS of $6.70, down 20.0% from $8.38
Net debt of $842.7 million at quarter end, a net leverage ratio of 2.55x; quarterly dividend of $0.30 per share
Champion Homes reported fourth-quarter fiscal 2026 results for the quarter ended March 28, 2026, with net sales up 4.6% to $621.3 million but net income down 18.4% to $29.7 million, driven by charges tied to acquisition contingent consideration and a product liability true-up. For the full year, net sales rose 7.3% to $2.7 billion and net income rose 4.3% to $206.9 million. The board also approved a $50.0 million increase to the share repurchase program, bringing the available amount to $150.0 million.
Q4 fiscal 2026 net sales rose 4.6% to $621.3 million; net income fell 18.4% to $29.7 million
Q4 diluted EPS was $0.53 versus $0.63 a year earlier; adjusted EPS was $0.68 versus $0.65
Full-year net sales rose 7.3% to $2.7 billion; net income rose 4.3% to $206.9 million; diluted EPS was $3.66 versus $3.42
Board increased the repurchase authorization by $50.0 million to $150.0 million; $200.0 million was repurchased in fiscal 2026
BJ's Wholesale Club reported first-quarter fiscal 2026 total revenues of $5.66 billion, up 9.9% from a year earlier, with comparable club sales up 6.3%. Net income fell 4.7% to $142.7 million and diluted EPS fell to $1.10 from $1.13, and the company said its fiscal 2026 guidance was unchanged.
Total revenues rose 9.9% to $5.66 billion; membership fee income rose 9.9% to $132.4 million.
Net income fell 4.7% to $142.7 million; adjusted EPS was $1.10 versus $1.14 a year earlier.
Adjusted EBITDA rose 4.3% to $298.1 million; SG&A increased to $806.0 million.
Fiscal 2026 guidance from March 5, 2026 is unchanged: adjusted EPS of $4.40 to $4.60 and capital expenditures of about $800 million.
Booz Allen reported fiscal 2026 results for the year ended March 31, 2026, with revenue down 6.4% to $11.2 billion while adjusted diluted EPS rose 2.5% to $6.51. Its fiscal 2027 guidance projects adjusted diluted EPS of $6.00 to $6.35, below the fiscal 2026 figure, and revenue of $11.2 billion to $11.7 billion.
Q4 fiscal 2026 revenue was $2.8 billion, down 6.4% year over year, while adjusted diluted EPS was $1.78, up 10.6%.
Fiscal 2026 GAAP diluted EPS was $6.90, down 4.8%, and net income was $851 million, down 9.0%.
Fiscal 2027 guidance: revenue $11.2 billion to $11.7 billion, adjusted diluted EPS $6.00 to $6.35, and free cash flow $825 million to $925 million.
The board declared a regular quarterly dividend of $0.59 per share, payable June 26, 2026, to holders of record on June 10, 2026.
Copart reported results for the third quarter of fiscal 2026, ended April 30, 2026. Revenue rose 2.1% to $1.2 billion and diluted earnings per share rose to $0.43 from $0.42, but net income attributable to Copart fell $4.2 million to $402.4 million. For shareholders, the quarter shows higher sales and per-share earnings, while lower net income and a 0.2% nine-month revenue decline are the less favorable results.
Q3 revenue was $1.2 billion, up $25.4 million, or 2.1%, from the same period last year.
Net income attributable to Copart was $402.4 million, down $4.2 million, or 1.0%.
Diluted EPS was $0.43 versus $0.42 a year earlier, an increase of 2.4%.
For the nine months, revenue was $3.5 billion, down 0.2%, and the company repurchased $1.6 billion of common stock.
Flowers Foods reported first-quarter 2026 results for the 16 weeks ended April 25, 2026. Net sales rose 1.1% to $1.572 billion, but net income fell 20.6% to $42.1 million, and the company reset its annual dividend rate to $0.50 per share while reaffirming its 2026 adjusted EPS outlook of $0.80 to $0.90.
Net sales rose 1.1% to $1.572 billion, helped by the Simple Mills acquisition and pricing/mix, while volume fell 3.3%.
Net income fell 20.6% to $42.1 million; adjusted diluted EPS fell to $0.29 from $0.35.
Quarterly dividend of $0.1250 per share, payable June 26, 2026, to shareholders of record June 12, 2026.
Fiscal 2026 guidance was reaffirmed, including adjusted diluted EPS of approximately $0.80 to $0.90.
Advanced Drainage Systems reported unaudited fourth-quarter and fiscal 2026 results for the period ended March 31, 2026. Fourth-quarter net sales rose 9.9% to $676.8 million, but net income from continuing operations fell 54.1% to $35.2 million, which the company attributed mainly to acquisition-related costs and restructuring expenses. The company also issued fiscal 2027 targets of $3.350 billion to $3.550 billion in net sales and $1.0 billion to $1.050 billion in Adjusted EBITDA, and its board declared a $0.20 per share cash dividend.
Q4 net sales rose $61.0 million, or 9.9%, to $676.8 million; the NDS acquisition contributed $48.8 million, and stormwater sales rose 2% on an organic basis.
Q4 diluted EPS from continuing operations was $0.43, down from $0.99; adjusted EPS rose 3.9% to $1.07.
Fiscal 2027 targets: net sales of $3.350 billion to $3.550 billion and Adjusted EBITDA of $1.0 billion to $1.050 billion, compared with fiscal 2026 net sales of $3,050.4 million.
Board approved a $0.20 per share cash dividend, payable June 15, 2026, to stockholders of record at the close of business on June 1, 2026.
Deere & Company reported second-quarter fiscal 2026 net income of $1.773 billion, or $6.55 per diluted share, down from $1.804 billion, or $6.64 per share, a year earlier, while net sales and revenues rose 5% to $13.369 billion. The company maintained its fiscal 2026 net income forecast of $4.5 billion to $5.0 billion, so shareholders see steady profit guidance alongside a year-over-year profit decline led by Production & Precision Agriculture.
Q2 net income was $1.773 billion ($6.55 per diluted share), down 2% from $1.804 billion ($6.64 per share); six-month net income was $2.429 billion, down 9%.
Production & Precision Agriculture net sales fell 14% to $4.503 billion and operating profit fell 39% to $706 million.
Small Agriculture & Turf net sales rose 16% to $3.485 billion and Construction & Forestry net sales rose 29% to $3.790 billion.
Fiscal 2026 net income is forecast at $4.5 billion to $5.0 billion, which the company said it maintained; the prior-year period included a $272 million IEEPA tariff refund recovery.
EnerSys reported fourth-quarter fiscal 2026 net sales of $988.0 million, up 1.3%, and adjusted diluted EPS of $3.19, above its $2.95 to $3.05 guidance. GAAP diluted EPS fell 15% to $2.05 because of $42.8 million in net-of-tax highlighted charges, and the company guided first-quarter fiscal 2027 net sales to $915 million to $955 million. The board also declared a $0.2625 quarterly dividend.
Q4 net sales $988.0 million, up 1.3%, at the low end of the $960 million to $1,000 million guidance range
Q4 adjusted diluted EPS $3.19 vs. guidance of $2.95 to $3.05; GAAP diluted EPS $2.05 vs. $2.41 a year earlier
Fiscal 2026 net sales $3,751.4 million, up 3.7%; GAAP diluted EPS $7.70 vs. $8.99
Q1 fiscal 2027 outlook: net sales $915 million to $955 million; adjusted diluted EPS $2.70 to $2.90. Dividend of $0.2625 payable July 2, 2026, to holders of record June 19, 2026
e.l.f. Beauty reported fourth-quarter fiscal 2026 net sales up 35% to $449.3 million and full-year net sales up 25% to $1,636.5 million. A $57.6 million non-cash charge tied to the rhode earnout turned the quarter to a GAAP net loss of $49.4 million, and adjusted diluted EPS fell to $0.32 from $0.78 a year earlier. The company also issued fiscal 2027 guidance calling for net sales of $1,835 million to $1,865 million and adjusted diluted EPS of $3.27 to $3.32.
Q4 net sales rose 35% to $449.3 million; adjusted EBITDA fell 28% to $58.8 million
Q4 GAAP diluted loss was $0.82 per share; adjusted diluted EPS was $0.32 versus $0.78 a year earlier
Full-year GAAP net income was $26.3 million, or $0.44 per diluted share; adjusted diluted EPS was $3.13 versus $3.39
Fiscal 2027 outlook: net sales $1,835 million to $1,865 million and adjusted diluted EPS $3.27 to $3.32
StepStone Group reported results for the fourth quarter and fiscal year ended March 31, 2026. Revenue rose sharply, but the full-year GAAP net loss attributable to the company grew to $535.8 million from $179.6 million, driven by equity-based compensation of $1.74 billion, while fourth-quarter ANI per share fell to $0.57 from $0.68.
Q4 total revenues were $588.6 million, up 56% from $377.7 million; Q4 net loss attributable to StepStone narrowed to $7.8 million from $18.5 million.
Full-year total revenues were $1.99 billion, up 70%, while full-year net loss attributable to StepStone was $535.8 million, or $6.78 per share, versus $179.6 million, or $2.52 per share.
Full-year ANI per share rose 5% to $2.16; Q4 ANI per share fell 16% to $0.57, and Q4 fee-related earnings rose 12% to $105.3 million.
Board declared a $0.28 quarterly dividend and a $0.55 supplemental dividend per Class A share, payable June 30, 2026, to holders of record on June 15, 2026.
Intuit reported fiscal third-quarter 2026 revenue of $8.6 billion, up 10%, and GAAP diluted earnings per share of $11.09, up 11%, and raised its full-year fiscal 2026 revenue guidance. The company also announced a plan to cut its full-time workforce by approximately 17% and estimated $300 million to $340 million in charges, mainly in the fourth fiscal quarter, which will weigh on reported GAAP results.
Q3 revenue of $8.6 billion, up 10%; non-GAAP diluted EPS of $12.80, up 10%
Full-year fiscal 2026 revenue guidance raised to $21.341 billion to $21.374 billion
Workforce reduction of approximately 17%, with charges of $300 million to $340 million, primarily in the quarter ending July 31, 2026
Quarterly dividend of $1.20 per share, payable July 17, 2026, to holders of record on July 9, 2026
Lowe's reported first-quarter 2026 results for the period ended May 1, 2026. Total sales rose to $23.1 billion from $20.9 billion, and comparable sales increased 0.6%, but diluted EPS was $2.90 versus $2.92 a year earlier. The company said adjusted diluted EPS, which excludes $96 million of acquisition-related amortization, rose 3.8% to $3.03, and it affirmed its full-year 2026 outlook.
Total sales were $23.1 billion versus $20.9 billion in the prior-year quarter; comparable sales rose 0.6%.
Diluted EPS was $2.90 versus $2.92 a year earlier; adjusted diluted EPS was $3.03, up 3.8%.
Net earnings were $1.6 billion, and the company paid $674 million in dividends during the quarter.
Full-year 2026 outlook was affirmed, including diluted EPS of approximately $11.75 to $12.25.
Roivant reported fourth-quarter net income attributable to the company of $303 million, compared with a loss of $206 million a year earlier, mainly due to a $770.2 million gain on the Moderna litigation settlement. Q4 revenue fell to $2.5 million from $7.6 million, and the full-year net loss attributable to the company widened to $299.8 million from $172.0 million, so the one-time gain does not reflect a steady operating improvement.
Q4 ended March 31, 2026: net income attributable to Roivant $303.0 million, or $0.28 diluted per share, versus a loss of $206.5 million ($0.29 per share) a year earlier
Gain on litigation settlement of $770.2 million; Q4 revenue $2.5 million versus $7.6 million
Full year: loss from continuing operations $397.9 million versus $729.8 million; net loss attributable to Roivant $299.8 million versus $172.0 million
Cash, cash equivalents and marketable securities of $4.3 billion as of March 31, 2026; Moderna to pay $950 million in July 2026 with an additional $1.3 billion contingent on an appeal
Immunovant reported results for the fourth quarter and fiscal year ended March 31, 2026, with its net loss widening as research and development spending rose to $142.3 million in the quarter, including $39.0 million in contractual costs tied to discontinuing batoclimab after two Phase 3 thyroid eye disease studies missed their primary endpoint. The company also shared preliminary open-label Week 16 data for IMVT-1402 in difficult-to-treat rheumatoid arthritis and said its $902.1 million in cash provides runway to a potential Graves' disease launch. For shareholders, the trial data are a positive step, but losses and spending increased, and the results remain preliminary.
Net loss for the quarter ended March 31, 2026 was $147.9 million ($0.73 per share), up from $106.4 million ($0.64 per share) a year earlier.
Full-year net loss was $505.6 million ($2.77 per share), compared with $413.8 million ($2.73 per share) in fiscal 2025.
IMVT-1402 showed an observed Week 16 ACR20 response rate of 72.7% in 165 evaluable patients in an open-label period; further updates are expected in the second half of calendar 2026.
Cash and cash equivalents totaled $902.1 million as of March 31, 2026.
VF Corp reported fourth-quarter revenue of $2.17 billion, up 1% from a year earlier, and an operating profit of $62 million versus a $73 million loss in the prior-year quarter. The quarter still produced a net loss of $119 million, or $0.30 per diluted share, mainly due to non-cash pension settlement charges tied to terminating its U.S. qualified plan. The company reinstated annual guidance for fiscal 2027 calling for revenue growth of 1% to 2% in constant currency, which signals management expects continued expansion.
Q4 FY2026 revenue was $2,166.0 million, up 1% from $2,143.8 million; excluding Dickies, revenue rose 8%
Q4 net loss was $119.3 million, or $0.30 per diluted share, versus a $0.39 loss a year earlier; pension settlement charges of about $158 million were excluded from adjusted results
Full-year FY2026 diluted EPS from continuing operations was $0.64 versus $0.18, and revenue was $9,605.2 million, up 1%
FY2027 guidance: revenue up 1% to 2% in constant currency, adjusted operating margin of about 8%, and free cash flow flat to up from $405 million; quarterly dividend of $0.09 payable June 18, 2026
Moving iMage Technologies reported fiscal third-quarter 2026 results for the period ended March 31, 2026. Revenue fell 4.9% to $3.39 million, while the net loss narrowed to $122,000, or $0.01 per share, from $240,000, or $0.02 per share, a year earlier. The company expects fourth-quarter revenue of approximately $5.3 million, which would be above the third-quarter level.
Q3 revenue was $3.39 million, down 4.9% from $3.57 million, with $460,000 from DCS cinema loudspeaker sales.
Gross margin rose to 34.8% from 29.8%, and the operating loss narrowed to $134,000 from $270,000.
The company expects Q4 revenue of approximately $5.3 million and a gross margin of 25% to 30%.
At March 31, 2026, cash was $2.4 million, working capital was $4.3 million, and the company reported zero debt.
Toll Brothers reported second-quarter fiscal 2026 results for the three months ended April 30, 2026, with net income of $260.6 million ($2.72 per diluted share), down from $352.4 million ($3.50) a year earlier. Home sales revenues fell to $2.51 billion from $2.71 billion as deliveries declined to 2,491 homes from 2,899. Management said it is raising full-year guidance across its key home building metrics based on year-to-date performance.
Net income $260.6 million, or $2.72 per diluted share, versus $352.4 million, or $3.50, a year earlier
Home sales revenues $2.51 billion on 2,491 deliveries, versus $2.71 billion on 2,899 deliveries
Adjusted home sales gross margin 26.2% versus 27.5%; SG&A at 10.3% of home sales revenues versus 9.5%
Full-year FY 2026 guidance includes 10,400 to 10,700 deliveries and an adjusted home sales gross margin of 26.10%
CAVA reported fiscal first quarter 2026 results for the 16-week period ended April 19, 2026. Revenue rose 32.2% to $434.4 million and same restaurant sales rose 9.7%, but net income fell to $23.6 million from $25.7 million, and diluted EPS was $0.20 versus $0.22. The company raised its fiscal 2026 guidance for same restaurant sales and Adjusted EBITDA.
Revenue of $434.4 million, up 32.2% from $328.5 million a year earlier; same restaurant sales rose 9.7%, including 6.8% guest traffic growth.
Net income of $23.6 million versus $25.7 million; the filing cites a lower tax benefit from equity-based compensation and higher depreciation and amortization.
Adjusted EBITDA of $61.7 million, up 37.6%; the company opened 20 net new restaurants, bringing the total to 459.
Fiscal 2026 guidance raised: same restaurant sales to 4.5% to 6.5% (from 3.0% to 5.0%) and Adjusted EBITDA to $181.0 million to $191.0 million (from $176.0 million to $184.0 million).
Eagle Materials reported fiscal 2026 revenue of $2.3 billion, up 2% and a record, but net earnings fell 9% to $423.8 million and diluted earnings per share fell 4% to $13.16. For the fourth quarter ended March 31, 2026, revenue rose 2% to $479.1 million while net earnings fell 10% to $60.2 million. The filing gives no earnings guidance, and management cited near-term uncertainty in demand.
Fiscal 2026 Light Materials operating earnings fell 15% to $331.4 million, mainly on lower Gypsum Wallboard volume and prices.
Fiscal 2026 Heavy Materials operating earnings rose 10% to $341.2 million, driven by higher Cement and Aggregates sales volume.
Company repurchased about 1.7 million shares for $382 million in fiscal 2026 and reported net debt of $1.5 billion at a 1.9x net leverage ratio.
Home Depot reported first quarter fiscal 2026 sales of $41.8 billion, up 4.8% from a year earlier, with comparable sales up 0.6%. Net earnings fell 4.2% to $3.3 billion, or $3.30 per diluted share, and the company reaffirmed its full-year fiscal 2026 guidance, so shareholders see higher sales alongside lower profit per share.
Sales of $41.8 billion, up $1.9 billion or 4.8%; comparable sales up 0.6%, with U.S. comparable sales up 0.4%
Diluted EPS of $3.30 vs. $3.45 a year earlier; adjusted diluted EPS of $3.43 vs. $3.56
Fiscal 2026 guidance reaffirmed, including diluted EPS growth of approximately flat to 4.0% from $14.23 in fiscal 2025
Operating income of $5.0 billion, down 3.0%; operating margin 11.9% vs. 12.9%
Vuzix reported first-quarter 2026 results for the three months ended March 31, 2026, with total sales down 12% to $1.4 million as lower M400 smart glasses unit sales reduced product revenue. The net loss attributable to common shareholders narrowed to $7.1 million, or $0.09 per share, from $8.6 million, or $0.11 per share, mainly because general and administrative expense fell on a $1.7 million decline in non-cash stock-based compensation. Revenue and gross loss moved in opposite directions to the bottom line, and operating cash outflow widened to $5.6 million.
Total sales were $1.4 million versus $1.6 million a year earlier, down 12%, driven by lower product sales.
Net loss attributable to common shareholders was $7.1 million, or $0.09 per share, compared with $8.6 million, or $0.11 per share.
Gross loss widened to $0.4 million from $0.3 million; general and administrative expense fell to $2.1 million from $4.0 million.
Cash used in operating activities was $5.6 million versus $3.5 million in the prior-year period.
Reading International reported first-quarter 2026 revenue of $45.1 million, up 12% from a year earlier, and a narrower operating loss of $3.6 million. The net loss attributable to the company widened to $8.1 million, or $0.36 per share, from $4.8 million, or $0.21 per share, because the year-earlier quarter included a $6.6 million gain on a property sale. Management said it is working to sell its Cinemas 1, 2, 3 building in New York City and is under contract to sell its Napier property in New Zealand.
Total revenue was $45.1 million, up 12% from $40.2 million in Q1 2025, with cinema revenue up 14% to $41.5 million.
Operating loss narrowed to $3.6 million from $6.9 million; EBITDA was negative $0.8 million versus positive $2.9 million a year earlier.
Net loss attributable to Reading International was $8.1 million ($0.36 per share), compared with $4.8 million ($0.21 per share) in Q1 2025.
As of March 31, 2026, cash and cash equivalents were $5.5 million and total gross debt was $184.6 million.
Data Storage Corp reported first-quarter 2026 sales of $346,707, up from $312,744 a year earlier, but posted a net loss attributable to common stockholders of $631,272, compared with net income of $24,078 in the prior-year quarter. The company also announced Sovereign AI Solutions, a wholly owned subsidiary for AI continuity infrastructure, and its cash flow statement shows $29.5 million spent on share repurchases in connection with a tender offer, with marketable securities falling to $9.6 million from $39.0 million at year-end 2025.
Sales were $346,707 versus $312,744 a year earlier; gross profit rose to $186,019 from $140,777.
Selling, general and administrative expense rose to $1,472,113 from $856,915, and the operating loss widened to $1,286,094 from $716,138.
Basic and diluted loss per share attributable to common stockholders was $(0.20), versus $0.00 a year earlier.
Share repurchases in connection with a tender offer totaled $29,528,957; Nexxis sales rose 10.9% and gross margin was 53.7% versus 45.0%.
Buda Juice reported first quarter 2026 results for the quarter ended March 31, 2026. Revenue rose 17.7% year over year to $3.5 million, but operating income fell to $0.6 million from $0.8 million and GAAP net income fell to $0.4 million from $0.8 million, with the company citing a temporary spike in lime costs that pressured gross margin.
Revenue increased 17.7% to $3.5 million from $3.0 million; gross profit rose 3.5% to $1.4 million
Operating income fell to $0.6 million from $0.8 million; net income was $0.4 million versus $0.8 million, with diluted EPS of $0.03
Non-GAAP net income was $0.6 million, flat with the prior year, and non-GAAP EPS was $0.05
Free cash flow was $1.1 million, up 37% from the prior-year period; subsequent to quarter end, Buda Fresh Cherry Limeade expanded into 246 Walmart stores across nine states
Pulmatrix reported a first quarter 2026 net loss of $1.2 million, or $0.32 per share, down from $1.8 million, or $0.50 per share, a year earlier. Cash and cash equivalents fell to $3.3 million, and the unaudited financials include going-concern language; the company says its cash is sufficient to fund operations at least through the anticipated closing of its proposed merger with Eos SENOLYTIX, expected in the third quarter of 2026.
Net loss of $1.2 million ($0.32 per share) for the three months ended March 31, 2026, versus $1.8 million ($0.50 per share) a year earlier
General and administrative expenses fell to $1.3 million from $1.8 million, mainly due to Form S-4 costs incurred in the prior-year quarter
Cash and cash equivalents were $3.3 million at March 31, 2026, down from $4.1 million at December 31, 2025
Merger agreement with Eos SENOLYTIX signed March 26, 2026; closing anticipated in the third quarter of 2026
Infleqtion reported first-quarter 2026 revenue of $9.5 million, up 14% from a year earlier, and raised its 2026 revenue guidance to at least $40 million. The net loss widened to $30.3 million from $6.0 million, though the per-share loss narrowed to $0.26 from $0.41 on a much larger share count after the go-public transaction.
Q1 2026 revenue of $9.5 million, up 14% year over year
GAAP net loss of $30.3 million, or $0.26 per share, versus a net loss of $6.0 million, or $0.41 per share, in Q1 2025
Go-public transaction expenses of $11.5 million and stock-based compensation of $8.3 million were included in GAAP results
Cash, cash equivalents and available-for-sale securities totaled $569 million as of March 31, 2026
Pixelworks reported first-quarter 2026 results, with net income of $80.6 million driven by a $85.2 million gain from discontinued operations tied to the January sale of its Shanghai subsidiary. Revenue was about $446,000, up from zero a year earlier, but the loss from continuing operations widened to $4.6 million from $2.8 million, including $2.0 million of restructuring costs. Shareholders also get a $5 million buyback authorization and cash of about $58 million with no debt.
Net income attributable to Pixelworks was $80.6 million, or $12.69 per basic share, versus a net loss of $7.8 million a year earlier.
Revenue was $446,000 versus zero in Q1 2025; loss from operations was $4.9 million versus $3.1 million.
Restructuring expense was $2.0 million; cash and cash equivalents were $57.8 million at March 31, 2026, with no debt.
The Board authorized a $5 million stock repurchase program on March 30, 2026, beginning May 15, 2026; the company targets cash operating expenses of about $2 million per quarter from Q2.
Research Solutions reported fiscal third-quarter 2026 results for the quarter ended March 31, 2026. Total revenue fell 4.3% to $12.1 million, while net income rose to $860,000, or $0.03 per diluted share, from $216,000, or $0.01 a year earlier, and annual recurring revenue grew 8.5% to $22.1 million.
Total revenue was $12.1 million, down from $12.7 million, as lower transaction revenue more than offset platform growth.
Net income was $860,000, or $0.03 per diluted share, versus $216,000, or $0.01, in the prior-year quarter.
Annual recurring revenue rose 8.5% to $22.1 million; operating cash flow was $1.0 million, down from $2.9 million.
Adjusted EBITDA rose 14% to $1.6 million; gross margin improved 220 basis points to 51.7%.
York Space Systems reported first-quarter 2026 revenue of $116.3 million, up 9% from a year earlier, but its net loss widened to $114.8 million from $11.7 million, driven largely by an $84.7 million stock compensation expense. The company reaffirmed its full-year 2026 revenue guidance of $545 million to $595 million, which matters to shareholders because revenue grew while profitability weakened sharply.
Revenue rose to $116.3 million from $106.3 million, while gross margin fell to 19% from 23%.
Net loss was $114.8 million versus $11.7 million a year earlier; adjusted EBITDA was a loss of $3.6 million versus a $5.5 million profit.
Full-year 2026 revenue guidance of $545 million to $595 million was reaffirmed as of May 14, 2026.
Backlog rose to $642 million from $543 million at December 31, 2025, and cash was $656 million at March 31, 2026.
Sutro Biopharma reported first quarter 2026 results, with revenue of $14.5 million, down from $17.4 million a year earlier, and a net loss of $38.5 million, down from $76.0 million. Net loss per share was $2.94 versus $9.08, and cash, cash equivalents and marketable securities rose to $202.6 million from $141.4 million at December 31, 2025, which the company says supports operations into at least the second quarter of 2028.
Revenue was $14.5 million for the quarter, versus $17.4 million in the first quarter of 2025, principally related to the Astellas collaboration.
Net loss was $38.5 million, or $2.94 per share, versus $76.0 million, or $9.08 per share, a year earlier.
Underwritten offering of 7,868,383 shares at $13.98 per share, with gross proceeds of $110.0 million before underwriting discounts and expenses.
The luvelta program has been closed, with no additional investment planned.
Figma reported first-quarter 2026 results on May 14, 2026, with revenue of $333.4 million, up 46% year over year and above its prior first-quarter guidance range. The company raised its full-year 2026 revenue guidance by $55 million, but its GAAP net loss was $142.4 million, compared with net income of $44.9 million a year earlier, so shareholders face a mixed picture of stronger sales and outlook alongside a larger GAAP loss.
Q1 2026 revenue was $333.4 million, up 46% year over year, versus 40% growth in Q4 2025.
Full-year 2026 revenue guidance is $1.422 billion to $1.428 billion, a $55 million raise; non-GAAP operating income guidance is $125.0 million to $135.0 million.
Second-quarter 2026 revenue outlook is $348.0 million to $350.0 million.
GAAP net loss was $142.4 million, or $(0.27) per share, versus net income of $44.9 million in Q1 2025; non-GAAP net income was $56.5 million.
Presurance Holdings reported first quarter 2026 results on May 13, 2026. Net income rose to $2.6 million from $522,000 as loss ratios improved, but gross written premiums fell 29.1% as the company exited commercial lines, and adjusted operating income was a loss of $2.8 million. The filing shows a smaller premium base and a combined ratio of 105.7%, which is still above the 100% level that indicates an underwriting profit.
Net income of $2.6 million, or $0.15 per share, versus $522,000, or $0.04 per share, in the first quarter of 2025
Gross written premiums fell 29.1% to $11.5 million, reflecting the exit from legacy commercial lines
Loss ratio improved to 56.2% from 89.7%; combined ratio was 105.7% versus 140.5%
Adjusted operating loss of $2.8 million, or $0.16 per share, versus a loss of $3.7 million, or $0.30 per share, a year earlier
NETSOL Technologies reported record third-quarter fiscal 2026 total net revenues of $19.8 million, up 13.0% year over year, driven in part by $4.7 million in license fees tied to a four-year, $50 million contract extension. Quarterly GAAP net income attributable to NETSOL fell slightly to $1.3 million, or $0.11 per diluted share, from $1.4 million, or $0.12, a year earlier, and the company reaffirmed its fiscal 2026 revenue guidance of $73 million.
Q3 total net revenues were $19.8 million, up from $17.5 million, including $4.7 million in license fees versus $1,198 a year earlier.
Q3 GAAP net income attributable to NETSOL was $1.3 million, or $0.11 per diluted share, compared with $1.4 million, or $0.12, in the prior-year quarter.
For the nine months ended March 31, 2026, the company reported a GAAP net loss attributable to NETSOL of $0.8 million, or $(0.07) per diluted share, versus net income of $0.3 million, or $0.03, a year earlier.
Fiscal 2026 full-year revenue guidance of $73 million was reaffirmed.
Innovative Aerosystems reported fiscal second-quarter 2026 results for the three months ended March 31, 2026, with net sales up 2% to $22.4 million. Net income fell to $3.4 million, or $0.19 per diluted share, from $5.3 million, or $0.30, a year earlier, as operating expenses rose to $6.5 million and one-time acquisition costs were incurred. Net debt rose to $48.3 million and the leverage ratio to 1.7x from 1.4x, as the company spent over $30 million on acquisitions in the first half.
Net sales were $22.4 million, up from $21.9 million a year earlier, while F-16 revenue declined by $7 million.
Net income was $3.4 million, or $0.19 per diluted share, versus $5.3 million, or $0.30, in the prior-year quarter.
Adjusted EBITDA was $6.8 million, down from $7.7 million; net debt was $48.3 million, and the leverage ratio was 1.7x at March 31, 2026.
Backlog was approximately $87.0 million as of March 31, 2026, up $7.4 million from the prior-year period.
Biofrontera reported first quarter 2026 revenue of $10.1 million, up about 17% from a year earlier, with gross margin near 80% after a restructured earnout following its October 2025 strategic transaction with Biofrontera AG. The net loss widened to $4.8 million from $4.2 million, though the loss per share improved to $0.41 from $0.47 on a higher share count, so shareholders get mixed signals on profitability.
Revenue was $10.1 million versus $8.6 million, driven by about 16% growth in Ameluz units sold and a price increase in Q4 2025.
Gross margin was about 80% versus about 62%; SG&A rose to $11.0 million from $8.7 million.
Net loss was $4.8 million, or $0.41 per share, versus $4.2 million, or $0.47 per share; Adjusted EBITDA improved to $(3.6) million from $(4.4) million.
Cash and cash equivalents were $6.3 million at March 31, 2026, with $70 thousand used in operations in the quarter.
Merlin, Inc. reported first-quarter 2026 results, its first report as a public company after its business combination closed on March 16, 2026. Revenue rose to $1.0 million from $0.9 million, but the GAAP net loss widened to $90.4 million from $12.7 million, and the adjusted EBITDA loss grew to $23.3 million from $10.4 million. The company also said a May 1, 2026 equity financing brought cash, cash equivalents, and short-term investments to about $183 million with no debt outstanding.
Total revenue of $1.0 million for Q1 2026, compared with $0.9 million in Q1 2025
GAAP net loss of $90.4 million, compared with $12.7 million; the filing attributes $87.8 million of the loss to a change in fair value of convertible promissory notes
Adjusted EBITDA loss of $23.3 million, compared with $10.4 million in Q1 2025
Cash, cash equivalents, and short-term investments of $122.8 million at March 31, 2026; about $183 million after the May 1, 2026 equity financing
YETI reported first quarter 2026 sales up 8% to $380.4 million, while diluted EPS fell 35% to $0.13 from $0.20 and adjusted EPS fell 16% to $0.26, including a $0.09 unfavorable net impact from incremental tariffs. The company raised its 2026 adjusted EPS outlook to $2.83 to $2.89 and increased its share repurchase authorization to $500 million, which matters to shareholders because the earnings forecast rose and buyback capacity expanded even though profit declined in the quarter.
Q1 2026 net sales rose 8% to $380.4 million; wholesale sales rose 19% to $183.6 million, while direct-to-consumer sales were flat at $196.8 million
Diluted EPS fell 35% to $0.13 from $0.20; net income fell 41% to $9.9 million; operating income margin was 3.3%
2026 adjusted EPS outlook raised to $2.83 to $2.89, up from $2.77 to $2.83; sales growth outlook low end raised to 7% to 8%
Board increased share repurchase authorization to $500 million available as of May 14, 2026; outlook includes $100 million in expected 2026 repurchases
Rapid Micro Biosystems reported first quarter 2026 total revenue of $8.0 million, up 11.1% from a year earlier, with product revenue up 36.0%. The net loss widened to $14.3 million from $11.3 million, and the company reaffirmed its full year 2026 total revenue guidance of $37.0 million to $41.0 million. For shareholders, revenue growth is offset by a larger loss and cash, short-term investments and restricted cash of about $23 million as of March 31, 2026.
Total revenue rose 11.1% to $8.0 million; product revenue rose 36.0% to $5.6 million, while service revenue fell 21.9% to $2.4 million.
Net loss was $14.3 million, or $0.31 per share, versus $11.3 million, or $0.26 per share, in the first quarter of 2025.
Full year 2026 total revenue guidance of $37.0 million to $41.0 million was reaffirmed, along with a gross margin target of approximately 20%.
Cash, short-term investments and restricted cash were about $23 million on March 31, 2026, down from $38.6 million on December 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.